Cause of death, by non-communicable diseases, ages 5-14, female in Norway
Norway: Cause of death, by non-communicable diseases, ages 5-14, female was 71.3% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14, female in Norway, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 5-14.
Analysis
Norway recorded 71.3% for cause of death, by non-communicable diseases, ages 5-14, female in 2021.
That represents a change of up 4.8% on the previous year and down 12.0% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, female in Norway peaked at 81.1% in 2010 and was at its lowest, 44.5%, in 2000.
Norway ranks 10th of 184 countries on this measure, in the top 10%.
Cause of death, by non-communicable diseases, ages 5-14, female in Norway, year by year
| Year | % of total female deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 44.5% | — |
| 2010 | 81.1% | +82.2% |
| 2015 | 74.7% | -7.9% |
| 2019 | 71.0% | -4.9% |
| 2020 | 68.1% | -4.1% |
| 2021 | 71.3% | +4.8% |
Norway compared with similar countries
- Norway's 71.3% is above the median for high income countries, which is 61.7%, 1.2× the median. (57 countries reporting)
- Norway's 71.3% is above the median for Europe & Central Asia, which is 60.6%, 1.2× the median. (47 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 44.5% | 44.5% | 44.5% | 1 |
| 2010s | 75.6% | 71.0% | 81.1% | 3 |
| 2020s | 69.7% | 68.1% | 71.3% | 2 |
Countries ranked near Norway
More health data for Norway
- Un projection of annual infant deaths, annual growth rate -7.69 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.337 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,212 deaths per 1,000 people (2090)
- Number of infants who die before age 1 12 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2021)
- Population ages 00-04, female, annual growth rate -0.217 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0238 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.0617 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, female in Norway?
- Cause of death, by non-communicable diseases, ages 5-14, female in Norway was 71.3% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, female recorded in Norway?
- The highest recorded value was 81.1% in 2010.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, female recorded in Norway?
- The lowest recorded value was 44.5% in 2000.
- How does Norway rank for cause of death, by non-communicable diseases, ages 5-14, female?
- Norway ranks 10th out of 184 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, female rising or falling in Norway?
- Over the last ten years it is down 12.0%. The long-run trend across the full record is rising.
- Where does this Norway data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.